Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(22), P. 13865 - 13880
Published: Nov. 18, 2024
Suppression
of
single-stranded
DNA
(ssDNA)
gap
accumulation
at
replication
forks
has
emerged
as
a
potential
determinant
chemosensitivity
in
homologous
recombination
(HR)-deficient
tumors,
ssDNA
gaps
are
transformed
into
cytotoxic
double-stranded
breaks.
We
have
previously
shown
that
the
histone
chaperone
CAF-1's
nucleosome
deposition
function
is
vital
to
preventing
degradation
stalled
correlating
with
HR-deficient
cells'
response
genotoxic
drugs.
Here
we
report
CAF-1-ASF1
pathway
promotes
both
wild-type
and
breast
cancer
(BRCA)-deficient
backgrounds.
show
this
independent
but
instead
may
rely
on
its
proper
localization
forks.
Moreover,
efficient
nascent
PrimPol,
enzyme
responsible
for
repriming
upon
stress,
dependent
CAF-1.
As
PrimPol
been
be
generating
byproduct
function,
role
recruitment
could
directly
impact
formation.
also
chemoresistance
observed
cells
when
CAF-1
or
ASF1A
lost
correlates
suppression
rather
than
protection
Overall,
work
identifies
an
unexpected
regulating
generation.
Molecular Cell,
Journal Year:
2024,
Volume and Issue:
84(4), P. 659 - 674.e7
Published: Jan. 23, 2024
Inactivating
mutations
in
the
BRCA1
and
BRCA2
genes
impair
DNA
double-strand
break
(DSB)
repair
by
homologous
recombination
(HR),
leading
to
chromosomal
instability
cancer.
Importantly,
BRCA1/2
deficiency
also
causes
therapeutically
targetable
vulnerabilities.
Here,
we
identify
dependency
on
end
resection
factor
EXO1
as
a
key
vulnerability
of
BRCA1-deficient
cells.
generates
poly(ADP-ribose)-decorated
lesions
during
S
phase
that
associate
with
unresolved
DSBs
genomic
but
not
wild-type
or
BRCA2-deficient
Our
data
indicate
BRCA1/EXO1
double-deficient
cells
accumulate
due
impaired
single-strand
annealing
(SSA)
top
their
HR
defect.
In
contrast,
retain
SSA
activity
absence
hence
tolerate
loss.
Consistent
EXO1-mediated
SSA,
find
BRCA1-mutated
tumors
show
elevated
expression
increased
SSA-associated
scars
compared
BRCA1-proficient
tumors.
Overall,
our
findings
uncover
promising
therapeutic
target
for
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(13)
Published: March 26, 2025
Apurinic/apyrimidinic
(AP)
sites
and
single-strand
breaks
arising
from
base
excision
repair
(BER)
during
the
misincorporation
of
damaged
nucleobases
may
hinder
replication
fork
stability
in
homologous
recombination–deficient
(HRD)
cells.
At
templated
AP
sites,
cross-links
between
DNA
5-hydroxymethylcytosine
binding,
embryonic
stem
cell–specific
(HMCES)
regulate
speed,
avoiding
cytotoxic
double-strand
breaks.
While
role
HMCES
at
template
strand
is
well
studied,
its
effects
on
nascent
are
not.
We
provide
evidence
that
HMCES–DNA-protein
(DPCs)
detrimental
to
BER-mediated
removal
5-hydroxymethyl-2′-deoxycytidine
(5hmdC)–derived
5-hydroxymethyl-2′-deoxyuridine
forks.
HRD
cells
have
heightened
HMCES-DPCs,
which
increase
further
upon
5hmdC
exposure,
suggesting
binds
both
spontaneous
5hmdC-induced
sites.
depletion
substantially
suppresses
5hmdC-mediated
defects,
chromosomal
aberrations,
cell
death
This
reveals
HMCES-DPCs
a
source
BER-initiated
single-stranded
gaps,
indicates
endogenous
DPCs
contribute
genomic
instability
tumors.
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(11), P. 6376 - 6391
Published: May 9, 2024
DNA
replication
faces
challenges
from
lesions
originated
endogenous
or
exogenous
sources
of
stress,
leading
to
the
accumulation
single-stranded
(ssDNA)
that
triggers
activation
ATR
checkpoint
response.
To
complete
genome
in
presence
damaged
DNA,
cells
employ
damage
tolerance
mechanisms
operate
not
only
at
stalled
forks
but
also
ssDNA
gaps
by
repriming
synthesis
downstream
lesions.
Here,
we
demonstrate
human
accumulate
post-replicative
following
replicative
stress
induction.
These
gaps,
initiated
PrimPol
and
expanded
long-range
resection
factors
EXO1
DNA2,
constitute
principal
origin
signal
responsible
for
upon
contrast
forks.
Strikingly,
loss
DNA2
results
synthetic
lethality
when
combined
with
BRCA1
deficiency,
BRCA2.
This
phenomenon
aligns
observation
alone
contributes
expansion
gaps.
Remarkably,
BRCA1-deficient
become
addicted
overexpression
EXO1,
BLM.
dependence
on
unveils
a
new
vulnerability
BRCA1-mutant
tumors,
shedding
light
potential
therapeutic
targets
these
cancers.
Trends in Genetics,
Journal Year:
2024,
Volume and Issue:
40(9), P. 757 - 771
Published: May 23, 2024
The
tumour-suppressive
roles
of
BRCA1
and
2
have
been
attributed
to
three
seemingly
distinct
functions
-
homologous
recombination,
replication
fork
protection,
single-stranded
(ss)DNA
gap
suppression
their
relative
importance
is
under
debate.
In
this
review,
we
examine
the
origin
resolution
ssDNA
gaps
discuss
recent
advances
in
understanding
role
BRCA1/2
suppression.
There
are
ample
data
showing
that
accumulation
BRCA1/2-deficient
cells
linked
genomic
instability
chemosensitivity.
However,
it
remains
unclear
whether
there
a
causative
function
cannot
unambiguously
be
dissected
from
other
functions.
We
therefore
conclude
closely
intertwined
not
mutually
exclusive.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 16, 2025
Abstract
Synthetic
lethality
in
homologous
recombination
(HR)‐deficient
cancers
caused
by
Poly
(ADP‐ribose)
polymerase
inhibitors
(PARPi)
has
been
classically
attributed
to
its
role
DNA
repair.
The
mode
of
action
PARPi
and
resistance
thereof
are
now
believed
be
predominantly
replication
associated.
Therefore,
effective
combinatorial
approaches
targeting
fork
processing
along
with
HR‐downregulation
target
HR‐proficient
possibly
PARPi‐resistant
tumors
warranted.
Stilbenes
a
privileged
class
molecules,
which
include
resveratrol,
pterostilbene,
piceatannol,
etc
,
that
modulate
both
processes
RAD51‐expression.
In
this
investigation,
screening
small
library
stilbenes,
including
in‐house
synthesized
trans
‐4,4′‐dihydroxystilbene
(DHS)
was
discovered
as
potent
natural
agent,
downregulates
RAD51
expression
HR
repair
(GFP‐reporter
assay).
DHS
induces
extensive
synergistic
cell
death
ovarian
when
combined
talazoparib
(PARPi).
Mechanistically,
elicits
replication‐stress
through
severely
impeding
progress,
speed,
inducing
fork‐asymmetry.
This
leads
robust
induction
single
stranded
(ssDNA)
gaps
poly‐ADP‐ribosylation
(PARylation)
S‐phase
cells,
signifying
issues
related
lagging
(Okazaki)
strand
synthesis.
PARPi,
abrogates
PARylation,
potentiates
induced
ssDNA
gaps,
their
conversion
into
lethal
double
breaks
MRE11
action.
Furthermore,
the
combination
is
highly
mitigating
tumor
xenograft
growth
SCID
mice
exhibited
good
therapeutic‐index
no/minimal
tissue‐toxicity.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3255 - 3255
Published: April 1, 2025
The
Saccharomyces
cerevisiae
chromosomal
architectural
protein
Hmo1
is
categorized
as
an
HMGB
protein,
it
contains
two
motifs
that
bind
DNA
in
a
structure-specific
manner.
However,
has
basic
C-terminal
domain
(CTD)
promotes
bending
instead
of
acidic
one
found
canonical
protein.
diverse
functions
genome
maintenance
and
gene
regulation.
It
implicated
damage
tolerance
(DDT)
enables
replication
to
bypass
lesions
on
the
template.
believed
direct
error-free
template
switching
(TS)
pathway
DDT
aid
formation
key
TS
intermediate
sister
chromatid
junction
(SCJ),
but
underlying
mechanisms
have
yet
be
resolved.
In
this
work,
we
used
genetic
molecular
biology
approaches
further
investigate
role
DDT.
We
extensive
functional
interactions
with
components
integrity
network
cellular
response
genotoxin
methyl
methanesulfonate
(MMS),
implicating
execution
or
regulation
homology-directed
repair,
replication-coupled
chromatin
assembly,
checkpoint.
Notably,
our
data
pointed
for
directing
SCJ
nuclease-mediated
resolution
helicase/topoisomerase
mediated
dissolution
processing/removal.
They
also
suggested
modulates
both
recycling
parental
histones
deposition
newly
synthesized
nascent
at
fork
ensure
proper
formation.
evidence
counteracts
function
histone
H2A
variant
H2A.Z
(Htz1
yeast)
possibly
due
their
opposing
effects
resection.
showed
negative
supercoiling
proxy
structure
MMS-induced
checkpoint
signaling,
which
independent
CTD
Hmo1.
Moreover,
obtained
indicating
whether
contributes
its
dependent
host's
background.
Taken
together,
findings
demonstrated
can
contribute
to,
regulate,
multiple
processes
via
different
mechanisms.
ACS Chemical Biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 16, 2025
Human
exonuclease
1
(EXO1),
a
member
of
the
structure-specific
nuclease
family,
plays
critical
role
in
maintaining
genome
stability
by
processing
DNA
double-strand
breaks
(DSBs),
nicks,
and
replication
intermediates
during
repair.
As
its
activity
is
essential
for
homologous
recombination
(HR)
fork
processing,
EXO1
has
emerged
as
compelling
therapeutic
target,
especially
cancers
marked
heightened
damage
stress.
Through
high-throughput
screening
45,000
compounds,
we
identified
seven
distinct
chemical
scaffolds
that
demonstrated
effective
selective
inhibition
EXO1.
Representative
compounds
from
two
most
potent
scaffolds,
C200
F684,
underwent
comprehensive
docking
analysis
subsequent
site-directed
mutagenesis
studies
to
evaluate
their
binding
mechanisms.
Biochemical
assays
further
validated
activity.
Tumor
cell
profiling
experiments
revealed
these
inhibitors
exploit
synthetic
lethality
BRCA1-deficient
cells,
emphasizing
specificity
potential
targeting
genetically
HR-deficient
(HRD)
driven
deleterious
mutations
HR
genes
like
BRCA1/2.
Mechanistically,
suppressed
end
resection,
stimulated
accumulation
breaks,
triggered
S-phase
PARylation,
effectively
disrupting
repair
pathways
are
cancer
survival.
These
findings
establish
promising
candidates
treatment
HRD
lay
groundwork
optimization
development
targeted
therapeutics.